INVO Bioscience (INVO) Institutional Ownership $2.20 +0.17 (+8.37%) As of 04/25/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for INVO Bioscience (NASDAQ:INVO)CurrentInstitutional OwnershipPercentage12.02%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$71.34KNumber ofInstitutional Sellers(last 12 months)0 Get INVO Insider Trade Alerts Want to know when executives and insiders are buying or selling INVO Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INVO Institutional Buying and Selling by Quarter INVO Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2024 CWC Advisors LLC.100,477$71K0.1%N/A2.638% 11/15/2023Sabby Management LLC231,023$183K0.1%N/A9.430% 11/14/2023AWM Investment Company Inc.32,000$25K0.0%-94.9%1.306% 11/4/2022Ieq Capital LLC50,000$53K0.0%N/A0.411% 8/12/2022AWM Investment Company Inc.623,860$411K0.1%-46.2%5.161% 5/12/2022 Magnus Financial Group LLC18,000$48K0.0%+80.0%0.149% 4/12/2022Eidelman Virant Capital11,062$29K0.0%N/A0.091% 2/15/2022Connors Investor Services Inc.49,000$163K0.0%+27.3%0.418% 2/10/2022 Magnus Financial Group LLC10,000$33K0.0%N/A0.085% 8/16/2021State Street Corp16,881$78K0.0%N/A0.161% 8/13/2021AWM Investment Company Inc.1,159,075$5.39M0.5%+22.0%11.077% 8/12/2021Essex Investment Management Co. LLC88,865$413K0.0%N/A0.849% 8/10/2021Connors Investor Services Inc.20,000$93K0.0%N/A0.191% 5/21/2021Citadel Advisors LLC22,721$98K0.0%N/A0.217% 5/19/2021Squarepoint Ops LLC32,661$141K0.0%N/A0.313% 5/18/2021Millennium Management LLC27,857$121K0.0%-50.3%0.267% 5/18/2021Citadel Advisors LLC22,721$98K0.0%N/A0.218% 5/13/2021AWM Investment Company Inc.950,125$4.11M0.5%+52.0%9.118% 5/12/2021Northern Trust Corp11,408$49K0.0%N/A0.109% 5/12/2021Geode Capital Management LLC81,346$352K0.0%N/A0.781% (Data available from 1/1/2016 forward) INVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INVO shares? During the previous two years, the following institutional investors and hedge funds held shares of INVO Bioscience shares: Sabby Management LLC ($183K), and CWC Advisors LLC. ($71K), AWM Investment Company Inc. ($25K).Learn more on INVO's institutional investors. What percentage of INVO Bioscience stock is owned by institutional investors? 12.02% of INVO Bioscience stock is owned by institutional investors. Learn more on INVO's institutional investor holdings. Which institutional investors have been buying INVO Bioscience stock? The following institutional investors have purchased INVO Bioscience stock in the last 24 months: Sabby Management LLC ($231.02K), and CWC Advisors LLC. ($100.48K). How much institutional buying is happening at INVO Bioscience? Institutional investors have bought a total of 331,500 shares in the last 24 months. This purchase volume represents approximately $253.89K in transactions. Which INVO Bioscience major shareholders have been selling company stock? The following institutional investors have sold INVO Bioscience stock in the last 24 months: AWM Investment Company Inc. ($591.86K). How much institutional selling is happening at INVO Bioscience? Institutional investors have sold a total of 591,860 shares in the last 24 months. This volume of shares sold represents approximately $467.69K in transactions. Related Companies PolyPid Institutional Ownership NeuroOne Medical Technologies Institutional Ownership Nephros Institutional Ownership Retractable Technologies Institutional Ownership NEXGEL Institutional Ownership Adagio Medical Institutional Ownership Beyond Air Institutional Ownership Vivos Therapeutics Institutional Ownership Co-Diagnostics Institutional Ownership PAVmed Institutional Ownership This page (NASDAQ:INVO) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
